The B.1.1.7 mutation was first discovered in the UK last year. It has been found in more than 100 countries around the world. That includes Thailand. and was accused of It's fueling a new wave of the epidemic. Many nations have seen record-breaking numbers of infected people.
Moreover, the US Centers for Disease Control and Prevention (CDC) said last week that It has become the most commonly seen mainstream strain in the United States. Amidst the number of infected cases that continue to increase
In a study analyzing a group of COVID-19 patients There were 496 people in serious condition who were admitted to various hospitals for treatment. of the United Kingdom in November and December last year. Comparison between patients infected with B.1.1.7 and other mutations The researchers found no difference in the risk of severe infection, death or other clinical outcomes. In patients infected with B.1.1.7 and other mutants
“From our information within various contexts and limitations of education in the real world Giving peace of mind at the beginning that Severe illness of a patient infected with the B.1.1.7 mutation who was admitted to the hospital. "This is no different from patients with severe symptoms from other mutant infections," the researchers said in the study.
Another study published in the medical journal The Lancet Public Health found that the vaccine appeared to be effective against the UK mutant. This is because there was no evidence of an increase in the reinfection rate compared to other mutants.
UK scientists have previously identified the UK mutant as being 40-70% more contagious than other major mutants, and this latest study confirms those findings. It is stated that the B.1.1.7 mutant actually spreads the infection more easily.
Rapid spread of COVID-19 mutants First found in the UK This comes amid news that Thailand found a case of the mutant infected last week. This is the first known community outbreak of the UK mutant in Thailand.
(Source: Reuters)
0 Comments